TERT, HRAS, and EIF1AX mutations in a patient with follicular adenoma.
CONCLUSIONS: We report a rare case of TERT, HRAS, and EIF1AX mutations in a patient with follicular adenoma. TERT promoter mutations may be an early genetic event in the molecular pathogenesis of follicular thyroid carcinoma.
PMID: 29669480 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
More News: Cancer & Oncology | Carcinoma | Cytology | Endocrinology | Genetics | Hypothyroidism | Pathology | Study | Thyroid | Thyroid Cancer